Subscribe to our Newsletter and get informed about new publication regulary and special discounts for subscribers!

IJPPE > Volume 3 > Metabolic Effects of Foenugreek, Nigella and...
< Back to Volume

Metabolic Effects of Foenugreek, Nigella and Termis: Review Article

Full Text PDF


Diabetes is a chronic metabolic disease, which affects large number of population all over the world. Diabetes is associated with many complications as dyslipidemia, coronary heart diseases and non alcoholic fatty liver diseases. More than 400 traditional medicinal plants have been recorded for helping in controlling such disease. This review discusses the effects of most common plants (Foenugreek, Nigella and Termis) used in Saudi Arabia and some other Arab countries as antidiabetic agents. The usage of the mixture or each plant alone corrected the blood glucose level and increase insulin secretion with definite increase in the number and diameter of beta pancreatic cells in the diabetic rats. Also, improve the associated dyslipidemia, and ameliorated most of all damage effects of Alloxan on hematological parameters present in diabetic rats. So, it can control most of the metabolic risk factors of coronary artery disease (CAD) in diabetic. Finally, it appeared to be a useful agent in improving fatty changes in the liver texture associated with DM. It can be concluded that, water extract of the mixture of Foenugreek, Nigella and Termis is the most powerful in amelioration hyperglycemia, dyslipidemia and most of all damage effects of Alloxan on the liver and hematological parameters.


International Journal of Pharmacology, Phytochemistry and Ethnomedicine (Volume 3)
W. S. Mohamed "Metabolic Effects of Foenugreek, Nigella and Termis: Review Article", International Journal of Pharmacology, Phytochemistry and Ethnomedicine, Vol. 3, pp. 90-96, 2016
Online since:
Jun 2016

[1] Rasool Hassan. Medicinal Plants (Importance and Uses). Pharmaceut Anal Acta. 3 (2012) 1000e139.

[2] Maiti R, Jana D, Das U, Ghosh D. Antidiabetic effect of aqueous extract of seed of tamarindus indica in streptozotocin induced diabetic rats. J Ethnopharmacol 92 (2004) 85-91.

DOI: 10.1016/j.jep.2004.02.002

[3] Abdel-Moneim A, El-Feki M and Salah E. Effect of Nigella Sativa, fish oil and gliclazide on Alloxan-diabetic rats. Biochemical and histopathological studies. J Egypt Ger Sc Zool. 23 (1999) 237-265.

[4] El-Dakhakhny M, Mady N, Lembert N and Ammon HP. The hypoglycemic effect of Nigella sativa oil is mediated by extrapancreatic actions. Planta Med. 68 (2002) 465-466.

DOI: 10.1055/s-2002-32084

[5] Kaleem M, Kirmani D, Asif M, Ahmed Q, Bano B. Biochemical effects of Nigella sativa L seeds in diabetic rats. Indian J Exp Biol 44 (2006) 745-748.

[6] Kavishankar G, Lakshmidevi N, Mahadeva M, Prakash H. Diabetes and medicinal plants-A review. Int J Pharm Biomed Sci. 2 (2011) 65-80.

[7] Wadkar K, Magdum C, Patil S, Naikwade N. Antidiabetic potential and Indian medicinal plants. J Herbal Med and Toxicol. 2 (2008) 45-50.

[8] Al-Habbori M, Raman A. Antidiabetic and hypocholesterolemic effects of fenugreek. Phytotherapy Research. 12 (1998) 233-242.

[9] Knecht K, Nguyen H, Auker A, Kinder D. Effects of extracts of lupine seed on blood glucose levels in glucose resistant mice: antihyperglycemic effects of Lupinus albus (white lupine, Egypt) and Lupinus caudatus. J. Herb Pharmacother. 6 (2006).

DOI: 10.1080/j157v06n03_04

[10] Mostafa AM, Serwah AH, Mohamed WS, Mohamed KM. Effects of some antidiabetic medicinal plants on pancreas and liver of diabetic Albino rats. Egyptian Journal of Hospital Medicine. 50 (2013) 156-168.

DOI: 10.12816/0000833

[11] Augusti K. and Sheela G. Theory and Practice of Histological Techniques. 4th edition. Churchill Living. Edinburgh and London. 1996; p.123.

[12] Meral I, Yener Z, Kahraman T, Mert N. Effect of Nigella sativa on glucose concentration, lipid peroxidation, anti-oxidant defense system and liver damage in experimentally induced diabetic rabbits. J. Vet. Med. A. Physiol. Pathol. Clin. Med. 48 (2001).

DOI: 10.1046/j.1439-0442.2001.00393.x

[13] Krishnaswami Vijayaraghavan. Treatment of dyslipidemia in patients with type 2 diabetes. Lipids in Health and Disease 2010; 9: 144-156.

DOI: 10.1186/1476-511x-9-144

[14] Saydah SH, Fradkin J, Cowie CC. Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. JAMA 2004; 291: 335-342.

DOI: 10.1001/jama.291.3.335

[15] Chahil TJ, Ginsberg HN. Diabetic dyslipidemia. Endocrinol Metab Clin North Am. 35 (2006) 491-510.

[16] Adiels M et al. Acute suppression of VLDL1 secretion rate of insulin is associated with hepatic fat content and insulin resistance. Diabetologia. 50 (2007) 2356-2365.

DOI: 10.1007/s00125-007-0790-1

[17] Mooradian AD et al. Obesity-related changes in high density lipoprotein metabolism. Obesity 16 (2008) 1152-1160.

DOI: 10.1038/oby.2008.202

[18] Marzouk M, Soliman A, Omar T. Hypoglycemic and antioxidative effects of fenugreek and termis seeds powder in streptozotocin-diabetic rats, European Review for Medical and Pharmacological Sciences. 17 (2013) 559-565.

[19] Hamden K, Jaouadi B, Carreau S, Bejar S, Elfeki A. "Inhibitory effect of fenugreek galactomannan on digestive enzymes related to diabetes, hyperlipidemia, and liver-kidney dysfunctions. Biotechnology and Bioprocess Engineering. 15 (2010) 407-413.

DOI: 10.1007/s12257-009-3037-9

[20] Naruszewicz M, Nowicka G, Klosiewicz-Latoszek L, Arnoldi A, Sirtori C. Effect of Lupin protein (Lupinus Albus) on cardiovascular risk factors in smokers with mild hypercholesterolemia [abstract]. Circulation 114 (2006) 874.

DOI: 10.1016/s1567-5688(06)81910-0

[21] Mohamed WS, Mostafa AM, Mohamed KM, Serwah AH. The effects of Fenugreek, Nigella and Termis seeds on lipid profile in diabetic albino rats. Annals of Biological Sciences 3 (2015) 1-9.

DOI: 10.1016/j.ajg.2014.12.003

[22] Duke J. Handbook of medicinal Herbs. 2nd ed. United States of America 2002, Pp: 15-51.

[23] Zahida T, Zeshan S, Nisar A, Mushtaq H. The Effects of Nigella sativa (Kalonji) on Lipid Profile in Patients with Stable Coronary Artery Disease in Multan, Pakistan. Pakistan Journal of Nutrition 10 (2011) 162-167.

DOI: 10.3923/pjn.2011.162.167

[24] Ghazi Mahmood, Aruna Bashir, Shah Murad, Javed Asghar, Shaheena Asif, Abdul Majeed Ch, Muhammad Aslam. Comparison of lipid lowering effects of Nigella Sativa and Gemfibrozil. International Journal of Pharmaceutical Research & Development 3 (2012).

[25] Ali B, Blunden G. Pharmacological and toxicological properties of Nigella sativa. Phytother Res. 17 (2003) 299-305.

DOI: 10.1002/ptr.1309

[26] Sirtori C, Lovati M, C Manzoni, Castiglioni S, Duranti M, Magni C, Morandi S, D'Agostina A, Arnoldi A. Proteins of white lupin seed, a naturally isoflavonepoor legume, reduce cholesterolemia in rats and increase LDL receptor activity in HepG2 cells. J Nutr. 134 (2004).

[27] Yoshie-Stark Y, Wa¨sche A. In vitro binding of bile acids by lupin protein isolates and their hydrolysates. Food Chem. 88 (2004) 179-184.

DOI: 10.1016/j.foodchem.2004.01.033

[28] Martins J, Riottot M, de Abreu M, Lanca M, Viegas-Crespo A, Almeida J, Freire J, Bento O. Dietary raw peas (Pisum sativum L. ) Reduce plasma total and LDL cholesterol and hepatic esterified cholesterol in intact and ileorectal anastomoses pigs fed cholesterol-rich diets. J Nutr. 134 (2004).

DOI: 10.1194/jlr.m500129-jlr200

[29] Bähr M, Fechner A, Krämer J, Kiehntopf M Jahreis G. Lupin protein positively affects plasma LDL cholesterol and LDL: HDL cholesterol ratio in hypercholesterolemic adults after four weeks of supplementation: a randomized, controlled crossover study. Nutrition Journal 12 (2013).

DOI: 10.1186/1475-2891-12-107

[30] Kumar P, Bhandari U, and Jamadagni S. Fenugreek Seed Extract Inhibit Fat Accumulation and Ameliorates Dyslipidemia in High Fat Diet-Induced Obese Rats. BioMed Research International ( 2014) 11.

DOI: 10.1155/2014/606021

[31] Adler A, Stratton I, Neil H, et al. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. BMJ 321 (2000) 412-419.

DOI: 10.1136/bmj.321.7258.412

[32] Paromita K, Ian P, and Richard D. The UK Prospective Diabetes Study (UKPDS): clinical and therapeutic implications for type 2 diabetes. Br J Clin Pharmacol. 48 (1999) 643-648.

DOI: 10.1046/j.1365-2125.1999.00092.x

[33] Helal E, Hasan M, Mustafa A and Al-Kamel A. Effect of Aloe vera extract on some physiological parameters in diabetic albino rats. The Egyptian Journal of Hospital Medicine 12 (2003) 53-61.

[34] Hongxiang H and Vay Liang W. Hypoglycemic herbs and their action mechanisms. Chin Med. 4 (2009) 11-14.

[35] Schreuder T, Verwer B, Nieuwkerk C, Mulder C. Nonalcoholic fatty liver disease. World J Gastroenterol. 14 (2008) 2474-2486.

[36] Takuma Y, Nouso K. Nonalcoholic steatohepatitis-associated hepatocellular carcinoma: our case series and literature review. World J Gastroenterol. 16 (2010) 1436-1441.

DOI: 10.3748/wjg.v16.i12.1436

[37] Farrell G, Larter C. Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology 43 (2006) S99e112.

DOI: 10.1002/hep.20973

[38] El-Serag H, Tran T, Everhart J. Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. Gastroenterology 126 (2004) 460-468.

DOI: 10.1053/j.gastro.2003.10.065

[39] Edmison J, McCullough AJ. Pathogenesis of non-alcoholic steatohepatitis: human data. Clin Liver Dis. 11(2007) 75-104.

DOI: 10.1016/j.cld.2007.02.011

[40] Martin A, Marja-Riitta T, Jan B. Fatty liver, insulin resistance, and dyslipidemia. Curr Diabetes Rep. 8 (2008) 60-64.

DOI: 10.1007/s11892-008-0011-4

[41] Angulo P. Nonalcoholic fatty liver disease. N Engl J Med. 346 (2002) 1221-1231.

[42] Alba L, Lindor K. Review article: non-alcoholic fatty liver disease. Aliment Pharmacol Ther. 17 (2003) 977-986.

DOI: 10.1046/j.1365-2036.2003.01493.x

[43] Levinthal G, Tavill A. Liver disease and diabetes mellitus. Clinical diabetes 1999; 17(2): 73-7.

[44] Mohamed W, Mostafa A, Mohamed K, Serwah A. Effects of fenugreek, Nigella, and Termis seeds in nonalcoholic fatty liver in obese diabetic albino rats., Arab Journal of Gastroenterology 16 (2015) 1-9.

DOI: 10.1016/j.ajg.2014.12.003

[45] Mofrad P, Contos M, Haque M, et al. Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values. Hepatology 37 (2003)1286-1292.

DOI: 10.1053/jhep.2003.50229
Show More Hide